AstraZeneca, Oxford vaccine prevents COVID-19 in big US study amid controversy overseas
A coronavirus vaccine developed by AstraZeneca and the University of Oxford was strongly protective against COVID-19 in the partners’ largest study yet, a significant finding for a shot that has been mired in controversy but could still play a crucial role. The result, which comes from a Phase 3 trial of 32,449 participants in the… Read More »